Erik R Wambre (Erik Wambre)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Mesenchymal Stem Cells

Immune Response

Atopic Dermatitis

Top Venues

Science translational medicine

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Astrid L Voskamp, Sugandhika Khosa, Tracy Phan, Hannah A DeBerg, Judy Bingham, Mark Hew, William B Smith, Jodie Abramovitch, Jennifer M Rolland, Matthew Moyle, Kari Christine Nadeau, Gideon Lack, Mark Larché, Erik R Wambre, Robyn Elizabeth O'Hehir, Pascal L C Hickey, Sara R Prickett
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy. Allergy 79 (2) (2023)
Astrid L Voskamp, Sugandhika Khosa, Tracy Phan, Hannah A DeBerg, Judy Bingham, Mark Hew, William B Smith, Jodie Abramovitch, Jennifer M Rolland, Matthew Moyle, Kari Christine Nadeau, Gideon Lack, Mark Larché, Erik R Wambre, Robyn Elizabeth O'Hehir, Pascal L C Hickey, Sara R Prickett
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy. Allergy (2023)
Brian C Ferslew, Ronald Smulders, Tong Zhu, Mary Beth Blauwet, Tomohiro Kusawake, Anna Spence, Kelly Aldridge, Hannah A DeBerg, Sugandhika Khosa, Erik R Wambre, Gurunadh R Chichili
Safety and immunopharmacology of ASP0892 in adults or adolescents with peanut allergy: two randomized trials. Allergy (2023)
Astrid L Voskamp, Sugandhika Khosa, Tracy Phan, Hannah A DeBerg, Judy Bingham, Mark Hew, William B Smith, Jodie Abramovitch, Jennifer M Rolland, Matthew Moyle, Kari Christine Nadeau, Gideon Lack, Mark Larché, Erik R Wambre, Robyn Elizabeth O'Hehir, Pascal L C Hickey, Sara R Prickett
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy. Allergy 79 (2) (2023)
Astrid L Voskamp, Sugandhika Khosa, Tracy Phan, Hannah A DeBerg, Judy Bingham, Mark Hew, William B Smith, Jodie Abramovitch, Jennifer M Rolland, Matthew Moyle, Kari Christine Nadeau, Gideon Lack, Mark Larché, Erik R Wambre, Robyn Elizabeth O'Hehir, Pascal L C Hickey, Sara R Prickett
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy. Allergy 79 (2) (2023)
Veronique Bajzik, Hannah A DeBerg, Nahir Garabatos, Blake J Rust, Kimberly K Obrien, Quynh-Anh Nguyen, Colin O'Rourke, Alex Smith, Alex H Walker, Charlie Quinn, Vivian H Gersuk, Mary Farrington, David Jeong, Brian P Vickery, Daniel C Adelman, Erik R Wambre
Oral desensitization therapy for peanut allergy induces dynamic changes in peanut-specific immune responses. Allergy 77 (8) (2022)
Erik R Wambre, Mary Farrington, Veronique Bajzik, Hannah A DeBerg, Marcella Ruddy, Michelle DeVeaux, Pretty Meier, David Robinson, Matt Cantor, Chengrui Huang, Jamie M Orengo, Claire Q Wang, Allen Radin
Clinical and immunological evaluation of cat-allergic asthmatics living with or without a cat. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 51 (12) (2021)
Erik R Wambre, Veronique Bajzik, Jonathan H DeLong, Kimberly O'Brien, Quynh-Anh Nguyen, Cate Speake, Vivian H Gersuk, Hannah A DeBerg, Elizabeth Whalen, Chester Ni, Mary Farrington, David Jeong, David Robinson, Carla J Greenbaum, Brian P Vickery, William Wai-Hung Kwok
A phenotypically and functionally distinct human TH2 cell subpopulation is associated with allergic disorders. Science translational medicine 9 (401) (2018)